{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:12:28Z","timestamp":1790712748022,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX1551"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1551"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370150"],"award-info":[{"award-number":["82370150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ3016"],"award-info":[{"award-number":["2024JJ3016"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30124"],"award-info":[{"award-number":["2023JJ30124"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ60169"],"award-info":[{"award-number":["2025JJ60169"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01247"],"award-info":[{"award-number":["2023J01247"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012771"],"award-info":[{"award-number":["2024A1515012771"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.drup.2026.101475","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:56:40Z","timestamp":1789603000000},"page":"101475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"Yunyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-9576","authenticated-orcid":false,"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1849","authenticated-orcid":false,"given":"Dan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-0168","authenticated-orcid":false,"given":"Jason H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-3639","authenticated-orcid":false,"given":"Erxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-6464","authenticated-orcid":false,"given":"Xiaoxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101475_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.drup.2026.101475_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2018.09.001","article-title":"SELEX methods on the road to protein targeting with nucleic acid aptamers","volume":"154","author":"Bayat","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.drup.2026.101475_bib3","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1242\/jcs.126128","article-title":"The LIR motif - crucial for selective autophagy","volume":"126","author":"Birgisdottir","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.drup.2026.101475_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.drup.2026.101475_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101475_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101475_bib7","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101475_bib8","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drup.2026.101475_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105919","article-title":"Efficient synthesis of artificial pharmaceutical solid-phase modules for constructing aptamer-drug conjugates","volume":"126","author":"Gao","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.drup.2026.101475_bib10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","article-title":"Recent progress of aptamer\u2212drug conjugates in cancer therapy","volume":"13","author":"He","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2026.101475_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/accountsmr.3c00249","article-title":"Leveraging aptamer-based DNA nanotechnology for bioanalysis and cancer therapeutics","volume":"5","author":"Huang","year":"2024","journal-title":"Acc. Mater. Res."},{"key":"10.1016\/j.drup.2026.101475_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jmb.2019.07.016","article-title":"Selective autophagy: ATG8 family proteins, LIR motifs and cargo receptors","volume":"432","author":"Johansen","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.drup.2026.101475_bib13","author":"Johnson","year":"2025","journal-title":"FDA Approv. INLEXZO\u2122 (gemcitabine intravesical Syst. ) Set. Transform. how Certain. Bladder Cancers are Treat."},{"key":"10.1016\/j.drup.2026.101475_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101475_bib15","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101475_bib16","doi-asserted-by":"crossref","first-page":"W283","DOI":"10.1093\/nar\/gkaf423","article-title":"GEPIA3: enhanced drug sensitivity and interaction network analysis for cancer research","volume":"53","author":"Kang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101475_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40824-021-00244-4","article-title":"Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy","volume":"25","author":"Kim","year":"2021","journal-title":"Biomater. Res."},{"key":"10.1016\/j.drup.2026.101475_bib18","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2026.101475_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101475_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41556-024-01572-y","article-title":"Phase separation of initiation hubs on cargo is a trigger switch for selective autophagy","volume":"27","author":"Licheva","year":"2025","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.drup.2026.101475_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s40242-022-2124-8","article-title":"Progress in DNA aptamers as recognition components for protein functional regulation","volume":"38","author":"Lingling","year":"2022","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.drup.2026.101475_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114168","article-title":"Translation of aptamers toward clinical diagnosis and commercialization","volume":"208","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.drup.2026.101475_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202370117","article-title":"A non-G-quadruplex DNA aptamer targeting NCL for diagnosis and therapy in bladder cancer","volume":"12","author":"Liu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drup.2026.101475_bib24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.gendis.2022.07.002","article-title":"Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma","volume":"10","author":"Liu","year":"2023","journal-title":"Genes. Dis."},{"key":"10.1016\/j.drup.2026.101475_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"Bmj"},{"key":"10.1016\/j.drup.2026.101475_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101475_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0849","article-title":"Comparison of sequential intravesical gemcitabine and docetaxel vs bacillus calmette-gu\u00e9rin for the treatment of patients with high-risk non-muscle-invasive bladder cancer","volume":"6","author":"McElree","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.drup.2026.101475_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101245","article-title":"Long non-coding RNA LRTOR drives osimertinib resistance in non-small cell lung cancer by boosting YAP positive feedback loop","volume":"83","author":"Miao","year":"2025","journal-title":"Drug. Resist. Updat."},{"issue":"5","key":"10.1016\/j.drup.2026.101475_bib29","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2026.101475_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41420-022-01242-8","article-title":"Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells","volume":"8","author":"Mun","year":"2022","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.drup.2026.101475_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109528","article-title":"Autophagy is a major metabolic regulator involved in cancer therapy resistance","volume":"36","author":"Poillet-Perez","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101475_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks339","article-title":"Automated 3D structure composition for large RNAs","volume":"40","author":"Popenda","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101475_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107902","article-title":"Strategies to manipulate the performance of aptamers in SELEX, post-SELEX and microenvironment","volume":"55","author":"Qi","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.drup.2026.101475_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101475_bib35","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/prot.26578","article-title":"RNA tertiary structure prediction using RNAComposer in CASP15","volume":"91","author":"Sarzynska","year":"2023","journal-title":"Protein. Struct. Funct. Bioinforma."},{"key":"10.1016\/j.drup.2026.101475_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2026.101475_bib37","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1073\/pnas.0602615103","article-title":"Aptamers evolved from live cells as effective molecular probes for cancer study","volume":"103","author":"Shangguan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101475_bib38","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1158\/1078-0432.CCR-04-0224","article-title":"The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma","volume":"10","author":"Spratlin","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101475_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110500119","article-title":"Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery","volume":"119","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101475_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.drup.2026.101475_bib41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.drup.2026.101475_bib42","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101475_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/bjc.2017.187","article-title":"Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma","volume":"117","author":"Vincenzi","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101475_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biochi.2020.11.018","article-title":"X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma","volume":"181","author":"Wang","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.drup.2026.101475_bib45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.cmet.2021.05.019","article-title":"Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1","volume":"33","author":"Wang","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.drup.2026.101475_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/5584_2022_732","article-title":"Aptamer-based tumor-targeted diagnosis and drug delivery","volume":"1409","author":"Woldekidan","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drup.2026.101475_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115149","article-title":"Aptamer functionalized cell membrane for brain and nerve cell sensing with high sensitivity and stability","volume":"227","author":"Wu","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.drup.2026.101475_bib48","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.1021\/jacs.9b03720","article-title":"Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding","volume":"141","author":"Wu","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2026.101475_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-024-01973-3","article-title":"Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101475_bib50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2018.07.015","article-title":"Molecular recognition and in-vitro-targeted inhibition of renal cell carcinoma using a DNA aptamer","volume":"12","author":"Zhang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drup.2026.101475_bib51","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/ijms18102142","article-title":"Recent advances in SELEX technology and aptamer applications in biomedicine","volume":"18","author":"Zhuo","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:43:26Z","timestamp":1790711006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":51,"alternative-id":["S1368764626001275"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101475","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101475"}}